CSF3 and allergic disease: Reasons for 15 cases that did not complete 6 cycles of neoadjuvant treatment included intolerable AEs (n = 13), death due to interstitial pneumonia without standardized treatment for the AE (n = 1), and patient withdrawal because of allergy to granulocyte colony-stimulating factor (n = 1).